Evidence map›Paper›PMID 29679113›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma.

Yimin Li, Frank Hofheinz, Christian Furth, Chen Lili, Wu Hua, Pirus Ghadjar, Sebastian Zschaeck

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Yimin LiDepartment of Radiation Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Frank HofheinzPET Center, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Christian FurthDepartment of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Chen LiliDepartment of Radiation Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Wu HuaDepartment of Nuclear Medicine, The Xiamen First Affiliated Hospital of Xiamen University, Xiamen, P. R. China.
Pirus GhadjarDepartment of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Sebastian ZschaeckDepartment of Radiation Oncology, Charité - Universitätsmedizin Berlin, Berlin, Germany. Sebastian.Zschaeck@charite.de.ORCID http://orcid.org/0000-0003-3109-0662
Charité - Universitätsmedizin Berlin · DEFirst Affiliated Hospital of Xiamen University · CNHelmholtz-Zentrum Dresden-Rossendorf · DE

Funding

Berliner Krebsgesellschaft ZSF201720Natural Science Foundation of Fujian Province 2008-59-11Nature Science Foundation of China 81101066Xiamen city science and technology project guidance 3502Z20134004
6 · The paper itself

Abstract

purpose

methodsThis retrospective evaluation included 72 patients with oesophageal squamous cell carcinoma treated with definitive RCT with curative intent. All patients underwent pretreatment and restaging FDG PET after receiving a radiation dose of 40-50 Gy. Standardized uptake values (SUV

results∆SUV

conclusionNTO-related tracer uptake during the course of treatment in patients with oesophageal carcinoma was shown to be of high prognostic relevance. Thus, metabolically activity of NTO measured in terms of ∆SUV

Indexed as

Positron-Emission TomographyAdultAgedBiological TransportCarcinoma, Squamous CellEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaFemaleFluorodeoxyglucose F18Follow-Up StudiesHumansMaleMiddle AgedPrognosisRetrospective StudiesTime FactorsFluorodeoxyglucose F18Definitive radiochemotherapyFDG PETInflammationNormal tissueOesophageal cancerResponse assessmentRestagingSide effects

Identifiers

PMID29679113
OpenAlexW2802735704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.